Open AccessA phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
Author(s) -
Autumn J. McRee,
Janine M. Davies,
Hanna Sanoff,
Richard M. Goldberg,
Stephen A. Bernard,
E. Claire Dees,
Kimberly L. Keller,
Anastasia Ivanova,
Bert H. O’Neil
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mwbd-k937
Subject(s) - panitumumab , refractory (planetary science) , medicine , everolimus , fluorouracil , oncology , chemotherapy , colorectal cancer , cancer , kras , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom